Literature DB >> 7686994

Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation.

C Legendre, E Thervet, B Page, A Percheron, L H Noël, H Kreis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7686994     DOI： 10.1016/0140-6736(93)92345-t

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  36 in total

1.  Long-term follow-up of transplanted kidneys according to plasma volume expander of kidney donors.

Authors:  M L Cittanova; J Mavré; B Riou; P Coriat
Journal:  Intensive Care Med       Date:  2001-10-09       Impact factor: 17.440

2.  The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients.

Authors:  Joachim Boldt; Stephan Suttner; Christian Brosch; Andreas Lehmann; Kerstin Röhm; Andinet Mengistu
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

3.  Hydroxyethyl starch: the Paradigm of Eminence-Based Versus Evidence-Based Medicine-1.

Authors:  Federico Bilotta; Giovanni Giordano; Fabrizio Caroletti; Francesco Pugliese
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-06-01

Review 4.  Hydroxyethylstarch as a risk factor for acute renal failure: is a change of clinical practice indicated?

Authors:  Joachim Boldt
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury.

Authors:  Nicolas Boussekey; Raphaël Darmon; Joachim Langlois; Serge Alfandari; Patrick Devos; Agnes Meybeck; Arnaud Chiche; Hugues Georges; Olivier Leroy
Journal:  Crit Care       Date:  2010-03-18       Impact factor: 9.097

6.  Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4.

Authors:  Ornella Piazza; Giuliana Scarpati; Rosalba Tufano
Journal:  Int J Gen Med       Date:  2010-10-05

Review 7.  Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM.

Authors:  Michael Joannidis; Wilfred Druml; Lui G Forni; A B Johan Groeneveld; Patrick Honore; Heleen M Oudemans-van Straaten; Claudio Ronco; Marie R C Schetz; Arend Jan Woittiez
Journal:  Intensive Care Med       Date:  2010-03       Impact factor: 17.440

8.  Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients.

Authors:  Franziska Schabinski; Janaina Oishi; Fabio Tuche; Alain Luy; Yasser Sakr; Donald Bredle; Christiane Hartog; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2009-06-17       Impact factor: 17.440

Review 9.  CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients.

Authors:  Christiane Hartog; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2009-06-17       Impact factor: 17.440

Review 10.  PRO: hydroxyethylstarch can be safely used in the intensive care patient--the renal debate.

Authors:  Joachim Boldt
Journal:  Intensive Care Med       Date:  2009-06-17       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.